# N-Acetylcysteine and Arginine Administration in Diabetic Patients

> **NCT00569465** · PHASE4 · TERMINATED · sponsor: **University of Turin, Italy** · enrollment: 24 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus
- Hypertension

## Interventions

- **DRUG:** Arginine
- **DRUG:** Acetylcysteine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00569465
- **Lead sponsor:** University of Turin, Italy
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-01
- **Primary completion:** —
- **Final completion:** 2006-01
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** End of the study
- **Last updated:** 2007-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00569465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00569465, "N-Acetylcysteine and Arginine Administration in Diabetic Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00569465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*